Fredrik Berg
Plus aucun poste en cours
Profil
Fredrik Berg formerly worked at Procordia AB, as Legal Counsel, Pharmacia AB, as Head-Legal & Intellectual Property from 1997 to 2001, Biovitrum AB, as SVP-Legal & Intellectual Property in 2010, Kabi Pharmacia, as Legal Counsel, Kabivitrum AB, as Legal Counsel, and Swedish Orphan Biovitrum AB, as Vice President & General Counsel.
Mr. Berg received his graduate degree from the University of Stockholm.
Anciens postes connus de Fredrik Berg
| Sociétés | Poste | Fin |
|---|---|---|
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Conseiller Juridique Général | 13/05/2010 |
| Pharmacia AB | Conseiller Juridique Général | 01/01/2001 |
| Kabi Pharmacia | Conseiller Juridique Général | - |
| Procordia AB | Conseiller Juridique Général | - |
| Kabivitrum AB | Conseiller Juridique Général | - |
Formation de Fredrik Berg
| University of Stockholm | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| Entreprise privées | 5 |
|---|---|
Biovitrum AB
Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. | Commercial Services |
| Pharmacia AB | Health Technology |
| Kabivitrum AB | |
| Procordia AB | Health Technology |
| Kabi Pharmacia |